EGFR In Non-Small Cell Lung Carcinoma

Around 10-35% of non-small cell lung carcinomas have drug-sensitizing mutations in the epidermal growth factor receptor (EGFR) gene. In these cases, tyrosine kinase inhibitor therapy is recommended. Find the latest research on EGFR and non-small cell lung carcinoma here.

January 21, 2022

Pretreatment neutrophil-to-lymphocyte ratio and cigarette smoking as prognostic factors in patients with advanced NSCLC treated with osimertinib.

Tuberculosis and Respiratory Diseases
Ji Young ParkKi-Suck Jung
January 21, 2022
Review

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence.

Current Oncology
Ilaria AttiliFilippo de Marinis
January 19, 2022

Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion.

Cancer Research and Treatment : Official Journal of Korean Cancer Association
Yeon Joo KimChang-Min Choi
January 19, 2022
Case Report

Immunotherapy in stage IV non-small cell lung cancer in a patient with Grave's disease: safety and biomarkers of response.

BMJ Case Reports
Marta VilaçaHelena Magalhães
January 17, 2022

Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Floriana Bardaro, Emanuele Stirpe
January 16, 2022

Amivantamab (JNJ-61186372) induces clinical, biochemical, molecular, and radiographic response in a treatment-refractory NSCLC patient harboring amplified triple EGFR mutations (L858R/ T790M/G796S) in cis.

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Misako NagasakaSai-Hong Ignatius Ou
January 13, 2022
Case Report

Case report: EGFR-mutant lung adenocarcinoma with the TP53 and RB1 mutations showed resistance to TKI therapy.

Annals of Palliative Medicine
Yiyu LuWeiguang Gu
January 13, 2022
Review

Pyrotinib in the treatment of advanced lung adenocarcinoma with HER2 exon 20 mutation: a case report and literature review.

Annals of Palliative Medicine
Ying LuoJun Chen
January 12, 2022
Review
Open Access

Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective.

Cancers
Radhashree MaitraTapan Kumar Mukherjee

Sign up to follow this feed and discover related papers.

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.

Large Cell Carcinoma of Lung

Large Cell Carcinoma of Lung is a non-small cell lung cancer that is characterized histologically by large malignant cells. Symptoms include fatigue and shortness of breath. Discover the latest research on Large Cell Carcinoma of Lung here.

Lung Adenocarcinoma

Lung adenocarcinoma is a type of non-small cell lung cancer and is the most frequent histological type of lung cancer, often triggered by aberrations in a driver oncogene. Here is the latest research.

Lung Squamous Cell Carcinoma

Lung squamous cell carcinomas represent 30% of all lung cancers. This feed focuses on genetic and environmental factors that affect this cancer, as well as current therapeutic strategies. Here is the latest research.

Meningeal Carcinomatosis

Meningeal carcinomatosis is a type of cancer that is spread into the leptomeninges within the brain, which are the inner two meningeal layers surrounding the brain. The most common types of cancer that spread to the leptomeninges via the CSF are breast cancer, melanoma and lung cancer. Here is the latest research on meningeal carcinomatosis.

Multiple Pulmonary Nodules

Multiple pulmonary nodules occur when there are two or more lesions that are 2-3 mm diameter. The most common source of the nodules is from cancer that has metastasized to the lungs. Other causes may be from benign tumors, autoimmune disorders, infection scars, enlarged lymph nodes and others. Here is the latest research on multiple pulmonary nodules.

Pleural Effusion, Malignant

When fluid accumulates within the pleural space, the area between the lungs and chest wall can contain malignant cells or tumor tissues, resulting from a malignant pleural effusion. The malignant cells often arise from metastasized cancer, most commonly breast cancer and lung cancer, Here is the latest research on malignant pleural effusions.

Small Cell Lung Carcinoma

Small cell lung carcinoma is a specific type of cancer that originates the lungs and is highly malignant. The type of cancer is determined by the distinctive cell type when viewed under a microscope. Here is the latest research on small cell lung carcinoma.

© 2022 Meta ULC. All rights reserved
/feed-previews/egfr-in-non-small-cell-lung-carcinoma/9279b0b9-f4c5-414a-8a66-8a23ceb06450